A citation-based method for searching scientific literature

Michael Weller, Martin van den Bent, Matthias Preusser, Emilie Le Rhun, Jörg C Tonn, Giuseppe Minniti, Martin Bendszus, Carmen Balana, Olivier Chinot, Linda Dirven, Pim French, Monika E Hegi, Asgeir S Jakola, Michael Platten, Patrick Roth, Roberta Rudà, Susan Short, Marion Smits, Martin J B Taphoorn, Andreas von Deimling, Manfred Westphal, Riccardo Soffietti, Guido Reifenberger, Wolfgang Wick. Nat Rev Clin Oncol 2021
Times Cited: 365



David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
Times Cited: 8562




List of shared articles



Times cited

Signaling pathways governing glioma cancer stem cells behavior.
Ava Nasrolahi, Shirin Azizidoost, Klaudia Radoszkiewicz, Sajad Najafi, Farhoodeh Ghaedrahmati, Omid Anbiyaee, Seyed Esmaeil Khoshnam, Maryam Farzaneh, Shahab Uddin. Cell Signal 2023
0

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
Julie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, Michael Weller, Timothy Cloughesy, Jana Portnow, Ovidiu Andronesi, Jill S Barnholtz-Sloan, Brigitta G Baumert, Mitchell S Berger,[...]. Neuro Oncol 2023
2

TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas.
Stefanie Quach, Adrien Holzgreve, Lena Kaiser, Marcus Unterrainer, Franziska J Dekorsy, Debie V Nelwan, Laura M Bartos, Sabrina V Kirchleitner, Jonathan Weller, Lorraine Weidner,[...]. Eur J Nucl Med Mol Imaging 2023
0

Association of RNA-modification "writer" genes with prognosis and response to immunotherapy in patients with low-grade glioma.
Lupeng Zhang, Chiwen Qu, Chen Shi, Fan Wu, Yifan Tang, Yue Li, Jinlong Li, Huicong Feng, Suye Zhong, Jun Yang,[...]. PLoS One 2023
0

Are Thalamic Intrinsic Lesions Operable? No-Man's Land Revisited by the Analysis of a Large Retrospective, Mono-Institutional, Cohort.
Paolo Ferroli, Francesco Restelli, Giacomo Bertolini, Emanuele Monti, Jacopo Falco, Giulio Bonomo, Irene Tramacere, Bianca Pollo, Chiara Calatozzolo, Monica Patanè,[...]. Cancers (Basel) 2023
0

Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature.
Annette Leibetseder, Johannes Leitner, Maximilian J Mair, Stephan Meckel, Johannes A Hainfellner, Martin Aichholzer, Georg Widhalm, Karin Dieckmann, Serge Weis, Julia Furtner,[...]. J Neurol 2022
1

Glioma: molecular signature and crossroads with tumor microenvironment.
Lennart Barthel, Martin Hadamitzky, Philipp Dammann, Manfred Schedlowski, Ulrich Sure, Basant Kumar Thakur, Susann Hetze. Cancer Metastasis Rev 2022
13

Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment.
Christoph Trautwein, Laimdota Zizmare, Irina Mäurer, Benjamin Bender, Björn Bayer, Ulrike Ernemann, Marcos Tatagiba, Stefan J Grau, Bernd J Pichler, Marco Skardelly,[...]. JCI Insight 2022
4

Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.
Sebastian Brandner, Alexandra McAleenan, Hayley E Jones, Ashleigh Kernohan, Tomos Robinson, Lena Schmidt, Sarah Dawson, Claire Kelly, Emmelyn Spencer Leal, Claire L Faulkner,[...]. Neuropathol Appl Neurobiol 2022
2

The diagnostic value of contrast enhancement on MRI in diffuse and anaplastic gliomas.
Aleksandrs Krigers, Matthias Demetz, Astrid E Grams, Claudius Thomé, Christian F Freyschlag. Acta Neurochir (Wien) 2022
1


Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas.
Peter Raab, Rouzbeh Banan, Arash Akbarian, Majid Esmaeilzadeh, Madjid Samii, Amir Samii, Helmut Bertalanffy, Ulrich Lehmann, Joachim K Krauss, Heinrich Lanfermann,[...]. Cancers (Basel) 2022
1


Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas.
Christina M Flies, Karlijn H van Leuken, Marlies Ten Voorde, Joost J C Verhoeff, Filip Y F De Vos, Tatjana Seute, Pierre A Robe, Theodoor D Witkamp, Jeroen Hendrikse, Jan Willem Dankbaar,[...]. Neurology 2022
2

Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics.
Anna L Koessinger, Catherine Cloix, Dominik Koessinger, Dieter Henrik Heiland, Florian J Bock, Karen Strathdee, Kevin Kinch, Laura Martínez-Escardó, Nikki R Paul, Colin Nixon,[...]. Cell Death Differ 2022
1

Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.
A M Zeitlberger, P M Putora, S Hofer, P Schucht, D Migliorini, A F Hottinger, U Roelcke, H Läubli, P Spina, O Bozinov,[...]. J Neurooncol 2022
0